论文部分内容阅读
弥漫大B细胞淋巴瘤(diffused large B cell lym-phoma,DLBCL)是恶性淋巴瘤WHO分类中最常见的非霍奇金淋巴瘤(non-Hodgkin’s lymphoma,NHL)的独立类型,但由于显著异质性的免疫、分子和细胞遗传学特征,其临床预后也相对不一致。目前使用的危险度分层尚不足以精确分辨出可能复发
Diffused large B cell lym-phoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma (NHL) in the WHO classification of malignant lymphoma, but due to significant heterogeneity Sexual immune, molecular and cytogenetic features are also associated with relatively different clinical outcomes. The risk stratification currently used is not sufficient to pinpoint the possible recurrence